Cargando…

Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists

BACKGROUND: For therapy of severe asthma 5 monoclonal antibodies have been available in Germany up to November 2022, but no clear rules exist on choice of initial therapy, assessment of response, and switch. OBJECTIVE: To assess current practice on all aspects of biologic therapy by specialists in G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suhling, Hendrik, Skowasch, Dirk, Bergmann, Karl-Christian, Mümmler, Carlo, Buhl, Roland, Ehmann, Rainer, Hamelmann, Eckard, Idzko, Marco, Margret Jandl, Schulz, Christian, Schmidt, Olaf, Taube, Christian, Korn, Stephanie, Milger, Katrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2023
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682826/ https://www.ncbi.nlm.nih.gov/pubmed/38033455 http://dx.doi.org/10.1016/j.waojou.2023.100844

Ejemplares similares

Fraction of exhaled nitric oxide is associated with disease burden in the German Asthma Net severe asthma cohort
por: Bal, Christina, et al.
Publicado: (2022)

Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study)
por: Korn, Stephanie, et al.
Publicado: (2023)

Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma
por: Drick, Nora, et al.
Publicado: (2020)

Kriterien zur Evaluation des Ansprechens auf Biologika bei schwerem Asthma – der Biologics Asthma Response Score (BARS)
por: Milger, Katrin, et al.
Publicado: (2023)

Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology
por: Pfaar, Oliver, et al.
Publicado: (2022)

Response to high-altitude triggers in seasonal asthmatics on and off inhaled corticosteroid treatment
por: Mertsch, Pontus, et al.
Publicado: (2022)

Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months
por: Kayser, Moritz Z, et al.
Publicado: (2021)

Future perspectives of anticholinergics for the treatment of asthma in adults and children
por: Buhl, Roland, et al.
Publicado: (2019)

Prevalence of Patients with Uncontrolled Asthma Despite NVL/GINA Step 4/5 Treatment in Germany
por: Bergmann, Karl-Christian, et al.
Publicado: (2022)

Health Care Situation in the Treatment of Uncontrolled GINA Step 4/5 Patients in Germany
por: Timmermann, Hartmut, et al.
Publicado: (2023)

COVID-19 vaccination and allergen immunotherapy (AIT) – A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI)
por: Klimek, Ludger, et al.
Publicado: (2021)

COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) – A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA)
por: Pfaar, Oliver, et al.
Publicado: (2021)

Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management
por: Kaplan, Alan, et al.
Publicado: (2020)

Cost-Effectiveness Of The SQ(®) Grass SLIT-Tablet In Children With Allergic Rhinitis: A German Payer Perspective
por: Vogelberg, Christian, et al.
Publicado: (2019)

Differential response to biologics in a patient with severe asthma and ABPA: a role for dupilumab?
por: Mümmler, Carlo, et al.
Publicado: (2020)

Precision medicine reaching out to the patients in allergology – a German-Japanese workshop report
por: Pfaar, Oliver, et al.
Publicado: (2021)

Severe allergic reactions to the COVID-19 vaccine – statement and practical consequences
por: Kleine-Tebbe, Jörg, et al.
Publicado: (2021)

Improved asthma control in patients with severe, persistent allergic asthma after 12 months of nightly temperature-controlled laminar airflow: an observational study with retrospective comparisons
por: Schauer, Uwe, et al.
Publicado: (2015)

Biologika und Covid-19
por: Buhl, Roland, et al.
Publicado: (2020)

Asthma exacerbations and worsenings in patients aged 1–75 years with add-on tiotropium treatment
por: Mark FitzGerald, J., et al.
Publicado: (2020)

Guideline on allergen immunotherapy in IgE-mediated allergic diseases: S2K Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), Society of Pediatric Allergology and Environmental Medicine (GPA), Medical Association of German Allergologists (AeDA), Austrian Society of Allergology and Immunology (ÖGAI), Swiss Society for Allergology and Immunology (SSAI), German Dermatological Society (DDG), German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), German Society of Pediatrics and Adolescent Medicine (DGKJ), Society of Pediatric Pulmonology (GPP), German Respiratory Society (DGP), German Professional Association of Otolaryngologists (BVHNO), German Association of Paediatric and Adolescent Care Specialists (BVKJ), Federal Association of Pneumologists, Sleep and Respiratory Physicians (BdP), Professional Association of German Dermatologists (BVDD)
por: Pfaar, Oliver, et al.
Publicado: (2022)

Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium
por: Hamelmann, Eckard
Publicado: (2018)

Long-acting muscarinic antagonists for the treatment of asthma in children—a new kid in town
por: Hamelmann, Eckard
Publicado: (2018)

Corrigendum to “Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium”
por: Hamelmann, Eckard
Publicado: (2019)

Asthma und Covid-19
por: Buhl, Roland, et al.
Publicado: (2020)

Course of respiratory allergy by treatment strategy based on German routine data
por: Weschenfelder, Ann-Kathrin, et al.
Publicado: (2017)

Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA)
por: Klimek, Ludger, et al.
Publicado: (2021)

Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany
por: Brehler, Randolf, et al.
Publicado: (2016)

Commentary: Treating Pediatric Asthma According Guidelines
por: Szefler, Stanley, et al.
Publicado: (2019)

Prevalence of oral corticosteroid use in the German severe asthma population
por: Taube, Christian, et al.
Publicado: (2019)

The effect of asthma specialist intervention on asthma control among adults()
por: Rosman, Yossi, et al.
Publicado: (2022)

Allergen reduction by nightly temperature controlled laminar airflow (TLA) decreases exacerbation rate in severe allergic asthma
por: Schauer, Uwe, et al.
Publicado: (2015)

A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT(®) Study Protocol
por: Buhl, Roland, et al.
Publicado: (2020)

Real‐life effectiveness of biological therapies on symptoms in severe asthma with comorbid CRSwNP
por: Mümmler, Carlo, et al.
Publicado: (2021)

Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI
por: Klimek, Ludger, et al.
Publicado: (2021)

Efficacy and Safety of Tiotropium in Children and Adolescents
por: Hamelmann, Eckard, et al.
Publicado: (2018)

Extension of mepolizumab injection intervals as potential of saving costs in well controlled patients with severe eosinophilic asthma()()
por: Bölke, Georg, et al.
Publicado: (2022)

COVID-19-Impfungen von Patienten mit Allergien und Typ2-entzündlichen Erkrankungen bei gleichzeitiger Antikörpertherapie (Biologika): Ein Positionspapier der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI) und dem Ärzteverband Deutscher Allergologen (AeDA)
por: Pfaar, Oliver, et al.
Publicado: (2021)

Pathway focused protein profiling indicates differential function for IL-1B, -18 and VEGF during initiation and resolution of lung inflammation evoked by carbon nanoparticle exposure in mice
por: Ganguly, Koustav, et al.
Publicado: (2009)

Decision-Making in the Pediatric Emergency Department—A Survey of Guidance Strategies among Residents
por: Gaus, Sebastian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pdmg2p1dsc18ntmsgus3ilt3ga